Audentes Therapeutics, Inc. Insider Trading for September 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Audentes Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Audentes Therapeutics, Inc. for September 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29 2017 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 28.25 | 672,000 | 18,984,000 | 4,129,638 | 4.8 M to 4.1 M (-14.00 %) |
| Sep 29 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Option Exercise | M | 2.19 | 3,750 | 8,195 | 37,347 | |
| Sep 29 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Sell | S | 30.00 | 3,750 | 112,500 | 0 | 3.8 K to 0 (-100.00 %) |
| Sep 29 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Buy | M | 2.19 | 3,750 | 8,195 | 3,750 | 0 to 3.8 K |
| Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.25 | 200 | 5,849 | 5,558 | 5.8 K to 5.6 K (-3.47 %) |
| Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.14 | 1,800 | 50,648 | 5,758 | 7.6 K to 5.8 K (-23.82 %) |
| Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.24 | 200 | 5,848 | 22,678 | 22.9 K to 22.7 K (-0.87 %) |
| Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.14 | 1,800 | 50,655 | 22,878 | 24.7 K to 22.9 K (-7.29 %) |
| Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.26 | 300 | 8,778 | 11,555 | 11.9 K to 11.6 K (-2.53 %) |
| Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.12 | 1,700 | 47,810 | 11,855 | 13.6 K to 11.9 K (-12.54 %) |
| Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.32 | 756 | 22,165 | 440,799 | 441.6 K to 440.8 K (-0.17 %) |
| Sep 29 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.31 | 4,244 | 120,150 | 441,555 | 445.8 K to 441.6 K (-0.95 %) |
| Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.88 | 359 | 10,366 | 7,558 | 7.9 K to 7.6 K (-4.53 %) |
| Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.07 | 641 | 17,991 | 7,917 | 8.6 K to 7.9 K (-7.49 %) |
| Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.85 | 364 | 10,501 | 24,678 | 25 K to 24.7 K (-1.45 %) |
| Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.06 | 636 | 17,847 | 25,042 | 25.7 K to 25 K (-2.48 %) |
| Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.89 | 400 | 11,555 | 13,555 | 14 K to 13.6 K (-2.87 %) |
| Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 27.99 | 600 | 16,796 | 13,955 | 14.6 K to 14 K (-4.12 %) |
| Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.76 | 7,594 | 218,428 | 445,799 | 453.4 K to 445.8 K (-1.67 %) |
| Sep 26 2017 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 27.85 | 7,406 | 206,244 | 453,393 | 460.8 K to 453.4 K (-1.61 %) |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | M | 0.78 | 8,458 | 6,597 | 209,750 | |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | M | 0.78 | 1,542 | 1,203 | 218,208 | |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 25.07 | 8,458 | 212,010 | 0 | 8.5 K to 0 (-100.00 %) |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 8,458 | 6,597 | 8,458 | 0 to 8.5 K |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 25.00 | 1,542 | 38,551 | 0 | 1.5 K to 0 (-100.00 %) |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 1,542 | 1,203 | 1,542 | 0 to 1.5 K |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Option Exercise | M | 2.19 | 3,750 | 8,195 | 41,097 | |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Sell | S | 25.00 | 3,750 | 93,750 | 0 | 3.8 K to 0 (-100.00 %) |
| Sep 19 2017 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Buy | M | 2.19 | 3,750 | 8,195 | 3,750 | 0 to 3.8 K |
| Sep 11 2017 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | X | 15.03 | 5,000 | 75,150 | 0 | |
| Sep 11 2017 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 22.35 | 5,000 | 111,750 | 4,801,638 | 4.8 M to 4.8 M (-0.10 %) |
| Sep 11 2017 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | X | 15.03 | 5,000 | 75,150 | 4,806,638 | 4.8 M to 4.8 M (+0.10 %) |
| Sep 01 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | M | 0.79 | 8,000 | 6,320 | 88,870 | |
| Sep 01 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 21.44 | 8,000 | 171,481 | 0 | 8 K to 0 (-100.00 %) |
| Sep 01 2017 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 8,000 | 6,320 | 8,000 | 0 to 8 K |